In summary, we show that acute ex vivo treatment of small biopsies of human colorectal tumours has considerable potential as means to reveal patient specific responses to MEK inhibitors and other therapeutic agents and to identify markers of response. Here, MAP2K7 is linked to colorectal neoplasm.